Skip to main content

Table 1 Participant demographic and baseline characteristics x ¯ ± s

From: Effectiveness of moxibustion treatment as adjunctive therapy in osteoarthritis of the knee: a randomized, double-blinded, placebo-controlled clinical trial

Characteristics Active group Sham group Total
(n = 55) (n = 55) (n = 110)
Age, years 65.80 ± 7.45 64.55 ± 8.38 65.17 ± 7.89
Gender, n (%)    
Male 16 (29.09) 21 (38.18) 37 (33.63)
Female 39 (70.90) 34 (61.81) 73 (66.36)
Target knees, n (%)    
1 knee 12 (21.82) 18 (32.73) 30 (27.27)
Both knees 43 (78.18) 37 (67.27) 80 (72.72)
Length of osteoarthritis diagnosis, n (%)    
<5 years 30 (54.55) 37 (67.27) 67 (60.90)
6-10 years 18 (32.73) 12 (21.82) 30 (27.27)
>10 years 7 (12.73) 6 (1.090) 13 (11.82)
Weight, kg 64.06 ± 9.02 66.01 ± 5.21 65.04 ± 6.33
Height, cm 1.63 ± 5.28 1.62 ± 1.45 1.62 ± 7. 98
Body mass index 24.11 ± 1.08 25.15 ± 2.41 24.63 ± 5.52
Outcomes (baseline)    
WOMAC pain score 6.73 ± 2.35 6.29 ± 2.70 6.51 ± 2.53
WOMAC function score 33.47.0 ± 15.37 30.99 ± 17.82 32.23 ± 16.61
  1. There were no differences between the groups in age, gender, course of disease, or condition of the diseased knee (P >0.05). There were no differences between the groups in Western Ontario and McMaster Universities’ Osteoarthritis Index (WOMAC) pain or physical function scores (P >0.05).